Your browser doesn't support javascript.
loading
CYP3A4-based drug-drug interaction: CYP3A4 substrates' pharmacokinetic properties and ketoconazole dose regimen effect.
Boulenc, Xavier; Nicolas, Olivier; Hermabessière, Stéphanie; Zobouyan, Isabelle; Martin, Valérie; Donazzolo, Yves; Ollier, Céline.
Afiliación
  • Boulenc X; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, 371 rue du Professeur J. Blayac, 34184, Montpellier Cedex 04, France. xavier.boulenc@sanofi.com.
  • Nicolas O; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, 371 rue du Professeur J. Blayac, 34184, Montpellier Cedex 04, France.
  • Hermabessière S; Clinical and Exploratory Pharmacology, Sanofi, Montpellier, France.
  • Zobouyan I; Clinical Documentation, Sanofi, Montpellier, France.
  • Martin V; Biostatistics, Sanofi, Chilly-Mazarin, France.
  • Donazzolo Y; Eurofins Optimed, Lyon, France.
  • Ollier C; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, 371 rue du Professeur J. Blayac, 34184, Montpellier Cedex 04, France.
Eur J Drug Metab Pharmacokinet ; 41(1): 45-54, 2016 Feb.
Article en En | MEDLINE | ID: mdl-25374256
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Citocromo P-450 CYP3A / Inhibidores del Citocromo P-450 CYP3A / Cetoconazol Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Eur J Drug Metab Pharmacokinet Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Citocromo P-450 CYP3A / Inhibidores del Citocromo P-450 CYP3A / Cetoconazol Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Eur J Drug Metab Pharmacokinet Año: 2016 Tipo del documento: Article